122
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Maintaining persistence and adherence with subcutaneous growth-hormone therapy in children: comparing jet-delivery and needle-based devices

, &
Pages 1255-1263 | Published online: 17 Sep 2014

References

  • National Institute for Health and Care ExcellenceHuman Growth Hormone (somatropin) for the Treatment of Growth Failure in ChildrenLondonNICE2010
  • YuenKCAminRDevelopments in administration of growth hormone treatment: focus on Norditropin® Flexpro®Patient Prefer Adherence2011511712421448295
  • van DongenNKapteinAAParents’ views on growth hormone treatment for their children: psychosocial issuesPatient Prefer Adherence2012654755322927747
  • National Institute for Health and Care ExcellenceMedicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting AdherenceLondonNICE2009
  • CutfieldWLindbergAAlbertsson WiklandKChatelainPRankeMBWiltonPFinal height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International BoardActa Paediatr Suppl199988428727510102057
  • FisherBGAceriniCLUnderstanding the growth hormone therapy adherence paradigm: a systematic reviewHorm Res Paediatr201379418919623635797
  • HaverkampFJohanssonLDumasHObservations of nonadherence to recombinant human growth hormone therapy in clinical practiceClin Ther200830230731618343269
  • RosenfeldRGBakkerBCompliance and persistence in pediatric and adult patients receiving growth hormone therapyEndocr Pract200814214315418308651
  • WickramasuriyaBPCaseyAAkhtarSFactors determining patient choice of device for GH therapyHorm Res2006651182216357486
  • Haymarket Medical MediaMIMS MagMar-May2014
  • KapteinAATransjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free devicePatient Prefer Adherence2013770370823926423
  • VerhagenAEbelsJTDogteromAAJonkmanJHPharmacokinetics and pharmacodynamics of a single dose of recombinant human growth hormone after subcutaneous administration by jet-injection: comparison with conventional needle-injectionEur J Clin Pharmacol1995491–269728751024
  • AgersøHMøller-PedersenJCappiSThomannPJesussekBSenderovitzTPharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringeJ Clin Pharmacol200242111262126812412826
  • CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
  • Pharmacy Quality AllianceProportion of days covered (PDC) as a preferred method of measuring medication adherence2014 Available from: http://pqaalliance.org/resources/adherence.aspAccessed March 18, 2014
  • MartinBCWiley-ExleyEKRichardsSDominoMECareyTSSleathBLContrasting measures of adherence with simple drug use, medication switching, and therapeutic duplicationAnn Pharmacother2009431364419126828
  • HalpernMTKhanZMSchmierJKRecommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataHypertension20064761039104816651464
  • YangMBarnerJCWorchelJFactors related to antipsychotic oversupply among Central Texas VeteransClin Ther20072961214122517692735
  • RobinsonAHankinsMWisemanGJonesMMaintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapseAliment Pharmacol Ther201338553123823834298
  • PetersonAMNauDPCramerJABennerJGwadry-SridharFNicholMA checklist for medication compliance and persistence studies using retrospective databasesValue Health200710131217261111
  • KaplanELMeierPNonparametric Estimation from Incomplete ObservationsJ Am Stat Assoc195853282457481
  • Ferring PharmaceuticalsZomacton: 10 mg injection [package insert]LondonFerring Pharmaceuticals2012
  • FreemanJVColeTJChinnSJonesPRWhiteEMPreeceMACross sectional stature and weight reference curves for the UK, 1990Arch Dis Child199573117247639543
  • DesrosiersPO’BrienFBlethenSPatient outcomes in the GHMonitor: the effect of delivery device on compliance and growthPediatr Endocrinol Rev20052Suppl 3S327S331
  • WeillJNiezPAdherence to the treatment with Zomajet, a needle-free device transjecting growth hormone: results of French observational surveyPoster presented at: European Society for Paediatric Endocrinology Annual ConferenceSeptember 19–22, 2013Milan, Italy
  • HorneRWeinmanJBarberNElliotRAMorganMConcordance, Adherence and Compliance in Medicine Taking: A Conceptual Map and Research PrioritiesLondonNational Institute for Health Research Service Delivery and Organisation R&D2006
  • VerripsGHHirasingRAFekkesMVogelsTVerloove-VanhorickSPDelemarre-Van de WaalHAPsychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapyActa Paediatr19988721541589512200
  • Department of HealthPharmacy in England: Building on Strengths – Delivering the FutureLondonDepartment of Health2008